Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year earnings per share growth rate
Percentile
P21
Within normal range
vs 3Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -45.71% |
| Q3 2025 | -16.67% |
| Q2 2025 | -20.00% |
| Q1 2025 | 56.14% |
| Q4 2024 | -171.43% |
| Q3 2024 | -16.67% |
| Q2 2024 | 28.00% |
| Q1 2024 | 44.44% |
| Q4 2023 | -136.84% |
| Q3 2023 | 5.00% |
| Q2 2023 | -2841.18% |
| Q1 2023 | 83.04% |
| Q4 2022 | 43.92% |
| Q3 2022 | -94.82% |
| Q2 2022 | -66.82% |
| Q1 2022 | 24.66% |
| Q4 2021 | 28.61% |
| Q3 2021 | -111.92% |
| Q2 2021 | -41.91% |
| Q1 2021 | -29.52% |
| Q4 2020 | -1.94% |
| Q3 2020 | 41.14% |
| Q2 2020 | -116.05% |
| Q1 2020 | 39.10% |
| Q4 2019 | -9.92% |
| Q3 2019 | 25.77% |
| Q2 2019 | 2.40% |
| Q1 2019 | 20.48% |
| Q4 2018 | 7.89% |
| Q3 2018 | 46.35% |
| Q2 2018 | -75.62% |
| Q1 2018 | 9.02% |
| Q4 2017 | 5.34% |
| Q3 2017 | 16.62% |
| Q2 2017 | -36.44% |
| Q1 2017 | 6.44% |
| Q4 2016 | 2.94% |
| Q3 2016 | -26.51% |
| Q2 2016 | 0.92% |
| Q1 2016 | 8.82% |